RecruitingNot ApplicableNCT07524231

Evaluation of the Effects of Laughter Yoga

Evaluation of the Effects of Laughter Yoga on Pain Intensity, Stress, and Beta-endorphin Levels in Patients With Multiple Sclerosis


Sponsor

Firat University

Enrollment

72 participants

Start Date

Mar 10, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This randomized controlled study aims to evaluate the effects of laughter yoga on pain intensity, fatigue, and beta-endorphin levels in patients with Multiple Sclerosis. Laughter yoga, a complementary therapy combining breathing exercises and laughter techniques, may help improve symptom management and psychological well-being in individuals with MS.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Being over 18 years old
  • Being able to communicate adequately
  • Volunteering to participate in the research

Exclusion Criteria7

  • Unwillingness to participate in the study
  • Having severe cognitive impairment that prevents understanding or participation in the intervention
  • Having a psychiatric disorder that may affect participation in the study
  • Experiencing an acute MS relapse during the study period
  • Having another serious neurological or chronic disease that may affect the study outcomes
  • Regular participation in another complementary therapy program similar to laughter yoga
  • Communication problems that prevent participation in the intervention sessions

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALLaughter Yoga

A complementary intervention including breathing exercises, stretching, relaxation techniques, and laughter exercises applied to patients with Multiple Sclerosis.


Locations(1)

Gül DURAL

Elâzığ, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07524231


Related Trials